Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Cancer Vaccines01:30

Cancer Vaccines

989
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
989
Electrical Current01:10

Electrical Current

6.9K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
6.9K
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups

29.4K

Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.4K
Significance of Displacement Current01:27

Significance of Displacement Current

5.8K
A displacement current is analogous to a real current in Ampère's law, participating in Ampère's law the same way as the usual conduction current. However, it is produced by a changing electric field. Displacement current is defined in terms of a time-varying electric field, and also has an associated displacement current density. By adding a term accounting for displacement current, Maxwell modified the existing Ampère's law, which is now called generalized Ampère's law.
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charting the Path Forward for HIV Immune-Based Prevention: Contributions of the Division of AIDS at NIAID.

Vaccines·2026
Same author

Attenuated estrogen signaling disrupts placentation and drives trophoblast defects in Down syndrome.

bioRxiv : the preprint server for biology·2026
Same author

TCCACS and MDR 2026 introduction.

Trauma surgery & acute care open·2026
Same author

Visitors' support of ocean protection in a low-use marine protected area: Gray's reef national marine sanctuary.

PloS one·2025
Same author

Optimizing human B cell repertoire analyses to interpret clinical data and design sequential HIV vaccines.

NPJ vaccines·2025
Same author

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines.

Frontiers in immunology·2025

Related Experiment Video

Updated: Jan 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Current advances in HIV vaccines.

M Patricia D'Souza1, Mary Allen, Rebecca Sheets

  • 1Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 6700B Rockledge Drive, Room 5127, Bethesda, MD 20892, USA. pdsouza@niaid.nih.gov

Current HIV/AIDS Reports
|August 11, 2005
PubMed
Summary

Developing a safe and effective HIV-1 vaccine remains crucial. Current strategies aim to reduce disease severity, with promising candidates advancing to efficacy trials, while research for broadly neutralizing antibodies continues.

More Related Videos

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
07:29

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging

Published on: December 1, 2011

42.0K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.7K

Related Experiment Videos

Last Updated: Jan 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K
Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
07:29

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging

Published on: December 1, 2011

42.0K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
11:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.7K

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Developing a preventive Human Immunodeficiency Virus type 1 (HIV-1) vaccine is a critical global health priority.
  • Recent progress includes better understanding of HIV envelope structure and improved analysis of immune responses to vaccines.
  • The pipeline of potential HIV vaccines has expanded, with initial efficacy trials now completed.

Purpose of the Study:

  • To summarize recent advances in HIV-1 vaccine development.
  • To highlight current strategies and their outcomes in preclinical and early clinical studies.
  • To outline the future trajectory of HIV vaccine research.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Analysis of advancements in understanding HIV-1 structure and immunology.
  • Evaluation of candidate vaccine performance in preclinical models and human trials.

Main Results:

  • Several preventive vaccine strategies show potential in attenuating disease, though not complete prevention, in nonhuman primates.
  • Promising candidate vaccines are progressing towards efficacy trials.
  • Research efforts are ongoing to develop vaccines that elicit broadly neutralizing antibodies against HIV-1.

Conclusions:

  • The field of HIV-1 vaccine development has seen significant progress.
  • Candidate vaccines are moving into later-stage trials, with a focus on disease attenuation.
  • Continued research is essential for identifying novel vaccine designs, particularly those inducing broadly neutralizing antibodies.